Thursday, 3 August 2017

Regeneron quarterly profit nearly doubles

(Reuters) - Regeneron Pharmaceuticals Inc reported a nearly 98 percent rise in quarterly profit on Thursday, partly helped by higher demand for its flagship eye treatment, Eylea.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)